A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives

Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
10/2011
10/12/2011	CN102210734A Atractylis oil dripping pill and preparation method thereof
10/12/2011	CN102210733A Method for preparing thiolated chitosan coated ginseng nano particles
10/12/2011	CN102210723A Method for preparing nano pills of black currant seed oil
10/12/2011	CN102210720A Method for preparing external plaster by utilizing Chinese medicinal water-soluble components
10/12/2011	CN102210711A Senso fat-soluble extract dry powder inhalation, preparation method and application thereof
10/12/2011	CN102210710A Bufo bufo gargarizans cantor skin extract gelskeleton sustained-release tablets and preparation method thereof
10/12/2011	CN102210706A Polypeptide donkey-hide gelatine dextran freeze-drying preparation and preparing process thereof
10/12/2011	CN102210705A Production process of polypeptide donkey-hide gelatin substitutive blood plasma
10/12/2011	CN102210694A Oral amifostine preparation and preparation method thereof
10/12/2011	CN102210690A Fasudil hydrochloride injection composition and preparation method thereof
10/12/2011	CN102210686A Pharmaceutical composition containing ganciclovir compound, and preparation method thereof
10/12/2011	CN102210679A Antibiotic compound containing piperacillin
10/12/2011	CN102210673A Cyclodextrin inclusion compound containing ligustilide, and preparation method thereof
10/12/2011	CN102210665A Method for preparing feed antibacterial agent by absorbing and grafting potassium diformate on epidesmine molecular screen
10/12/2011	CN102210664A Implant for treating glioblastoma and preparation method thereof
10/12/2011	CN102210661A Oral instant membrane and preparation method thereof
10/12/2011	CN102210657A Prulifloxacin tablets and preparation process thereof
10/12/2011	CN102210656A Medicinal composition containing carbazochrome sodium sulfonate compound and preparation method thereof
10/12/2011	CN102210655A Cefpiramide sodium micro-spheres and preparing method thereof
10/12/2011	CN102210653A Burdock aglycone microemulsion
10/12/2011	CN102210652A Lipid microsphere injection of larotaxel phospholipid compound, and preparation method thereof
10/12/2011	CN102210651A Nitrofurazone washing fluid, preparation method and application thereof
10/12/2011	CN102210650A Prednicarbate emulsifiable paste and preparation method thereof
10/12/2011	CN102210648A High-concentration furacilin micro emulsion washing fluid and preparation method and use thereof
10/12/2011	CN102210647A Gel sustained-release preparation capable of improving ring-close rates of camptothecin and derivative lactone ring thereof
10/12/2011	CN102210646A Human rabies vaccine gel and preparation method thereof
10/12/2011	CN102210645A Lutein ophthalmic nanocapsule in-situ gel preparation and preparation method thereof
10/12/2011	CN102210635A Polyamide 10.10 powder and its use in personal care products
10/12/2011	CN102210630A System and method for preparing nosiheptide premix particles
10/12/2011	CN101822741B Oral ulcer healing membrane with traditional Chinese medicine bioadhesive one-way medicine release
10/12/2011	CN101810595B Preparation method of calcium alginate microcapsule
10/12/2011	CN101732262B Method for preparing freeze-drying particle preparation for injection
10/12/2011	CN101721368B Medicinal composition for aerosol
10/12/2011	CN101693011B Preparation method of magnetic medicine-carrying nano-particle
10/12/2011	CN101569608B Oral solid lipid nano-particle preparation of calcitonin and preparation method thereof
10/12/2011	CN101496808B Compound xanthophyll microcapsule for sight protection and preparation method thereof
10/12/2011	CN101415732B Aryl/alkyl vinyl sulfone hyaluronic acid derivatives
10/12/2011	CN101002765B Compressed formed preparation
10/11/2011	US8035185 Electrode, method of making same, photoelectric transfer element, method of manufacturing same, electronic device and method of manufacturing same
10/11/2011	US8034981 Modified bio-related substance, process for producing the same, and intermediate
10/11/2011	US8034959 Methods of treating cancer with an antibody-drug conjugate
10/11/2011	US8034845 administering to animals antibiotic deriavtives such as florfenicol or flunixin, for prevention of urogenital, respiratory system and gastrointestinal disorders, vision defects and mastitis; veterinary medicine
10/11/2011	US8034825 Chemically modified small molecules
10/11/2011	US8034795 Taxanes covalently bounded to hyaluronic acid or hyaluronic acid derivatives
10/11/2011	US8034787 Enzyme-cleavable prodrug compounds
10/11/2011	US8034618 PTH containing cell growth matrix
10/11/2011	US8034379 Hydrophilic gel foaming matrix; cellulose ethers
10/11/2011	US8034378 water; a biodegradable microparticle of a polylactone, polyorthoester, a polyanhydride, or a polycyanoacrylate; an antigen adsorbed to the microparticle; and a phospholipid adjuvant with one or more phosphoric acid or phosphodiester groups and linear alkane groups
10/11/2011	US8034371 Intranasal compositions
10/11/2011	US8034363 Sustained release systems of ascorbic acid phosphate
10/11/2011	US8034360 Use of human prostate cell lines in cancer treatment
10/11/2011	US8034348 Prevention and treatment of amyloidogenic disease
10/11/2011	US8034339 administering an antibody that specifically binds to the amyloid deposit or a component thereof; can be a human, humanized, chimeric or nonhuman antibody and can be monoclonal or polyclonal; also a novel monoclonal antibody which specifically binds to an epitope within residues 13-28 of A beta
10/11/2011	US8034325 Powder formed of particles of biliquid foam entrapped within polymeric matrix
10/11/2011	US8034314 Photoreactive compound specifically binding to calcium binding proteins
10/11/2011	US8033977 Methods of enhancing radiation effects with metal nanoparticles
10/11/2011	DE202008018063U1 Pharmazeutischer Hilfsstoffkomplex Pharmaceutical excipient complex
10/11/2011	CA2727735C Disinfectant and/or bactericidal aqueous compositions
10/11/2011	CA2553413C Insecticidal combination effective against fleas on mammals, particularly cats and dogs
10/11/2011	CA2520523C Oral formulations of cladribine
10/11/2011	CA2506930C Dosage forms containing a proton pump inhibitor, a nsaid, and a buffer
10/11/2011	CA2483000C Oral care compositions containing ovomucin
10/11/2011	CA2464578C Pharmaceutical containing 3-(3-dimethylamino-1-ethyl-2-methyl-propyl)phenol and providing delayed release of the active ingredient
10/11/2011	CA2464322C Methods of treatment using a gastric retained gabapentin dosage
10/11/2011	CA2457876C Process for the preparation of activated polyethylene glycols
10/11/2011	CA2457124C Topical composition, topical composition precursor, and methods for manufacturing and using
10/11/2011	CA2457027C Chitin microparticles and their medical uses
10/11/2011	CA2456180C Aqueous dispersion comprising stable nanoparticles of a water-insoluble active and an excipient like middle chain triglycerides (mct)
10/11/2011	CA2447663C Composition and use of substances for the stabilization of sulphur-containing amino acids
10/11/2011	CA2447538C Cellular signal-responsive gene transcriptional regulation system
10/11/2011	CA2442993C Nucleic acid and corresponding protein entitled 158p3d2 useful in treatment and detection of cancer
10/11/2011	CA2442151C Stable solution of reduced coenzyme q
10/11/2011	CA2438116C Amphoteric liposomes and the use thereof
10/11/2011	CA2424734C Nanoparticles comprising a metallic or semiconductor core which is covalently bound to a plurality of carbohydrate ligands
10/11/2011	CA2402773C Tissue bulking and coating compositions
10/11/2011	CA2393410C Phosphonate compounds
10/11/2011	CA2382177C Method of treating body insect infestation
10/11/2011	CA2341356C Poxvirus with targeted infection specificity
10/11/2011	CA2237578E Copolymers of tyrosine-based polycarbonate and poly(alkylene oxide)
10/07/2011	CA2736448A1 Polyamide 1010 powder and its use in personal care products
10/06/2011	WO2011123866A1 Abuse-deterrent transdermal formulations of opiate agonists and agonist-antagonists
10/06/2011	WO2011123665A1 Methods and compositions for the treatment of burns and wounds
10/06/2011	WO2011123416A1 Injectable drug delivery formulation
10/06/2011	WO2011123027A1 Improved treatment of renal cell carcinoma
10/06/2011	WO2011122934A2 Bioencapsule and method thereof
10/06/2011	WO2011122923A2 Long-acting interferon beta formulation using immunoglobulin fragment
10/06/2011	WO2011122922A2 Long-acting human follicle-stimulating hormone formulation using immunoglobulin fragment
10/06/2011	WO2011122921A2 An insulin conjugate using an immunoglobulin fragment
10/06/2011	WO2011122620A1 Pharmaceutical preparation comprising phenylalanine derivative
10/06/2011	WO2011122477A1 Vesicle-containing composition
10/06/2011	WO2011121989A1 Coating fat composition and particulate composition using same
10/06/2011	WO2011121833A1 Water-soluble iron supply agent with reducing power and with coffee grounds or tea dregs as raw material
10/06/2011	WO2011121824A1 Orally disintegrating tablet
10/06/2011	WO2011121823A1 Particulate pharmaceutical composition for oral administration
10/06/2011	WO2011121559A2 Stabilized antibody preparations and uses thereof
10/06/2011	WO2011121425A1 Pharmaceutical powder composition for inhalation
10/06/2011	WO2011121360A1 Volatile liquid transfer materials comprising balsa wood
10/06/2011	WO2011121306A1 Stabilisation of viral particles
10/06/2011	WO2011121301A1 Excipients for stabilising viral particles, polypeptides or biological material
10/06/2011	WO2011121161A1 New ammonium phenoxide dendrimers having a carbosilane structure and uses thereof

1 ... 356 357 358 359 360 361 362 363 364 365 366 367 368 369 370 371 372 373 374 375 376 ... 1712